A search of the same databases for commonly used AHAs (not including insulin), using data from 1968 through the first quarter of 2009, revealed cases of severe pancreatitis (i.e. haemorrhagic or necrotising) in which the following drugs were considered suspect therapy: acarbose, metformin, glimepiride, repaglinide, pioglitazone and rosiglitazone, in addition to exenatide and sitagliptin. Here, INS is linked to pancreatitis.